Related Experiment Video
Updated: Jun 17, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
The complement component 5 gene and age-related macular degeneration
Dominique C Baas1, Lintje Ho, Sarah Ennis
1Department of Clinical and Molecular Ophthalmogenetics, The Netherlands Institute for Neuroscience, an institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.
Genetic variants in the complement component 5 (C5) gene were studied for association with age-related macular degeneration (AMD). Initial findings showed associations, but these were not consistently replicated across multiple populations, suggesting no clear link for C5 gene variants in AMD.
Area of Science:
- Genetics
- Ophthalmology
- Immunology
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
- The complement system, particularly complement component 5 (C5), is implicated in AMD pathogenesis.
- Genetic variations in complement genes are potential risk factors for AMD.
Purpose of the Study:
- To investigate the association between single nucleotide polymorphisms (SNPs) in the complement component 5 (C5) gene and the risk of developing age-related macular degeneration (AMD).
- To determine if C5 gene variants contribute independently to AMD risk.
Main Methods:
- Utilized combined data from three large AMD case-control studies and one prospective population-based study (The Rotterdam Study).
- Genotyped fifteen SNPs across the C5 gene in an initial cohort (AMRO-NL study) of 2599 AMD cases and 3458 controls.
- Performed replication testing of significant SNPs in independent study populations from the Netherlands, UK, and US.
Main Results:
- Initial analysis of the AMRO-NL study revealed significant allelic or genotypic associations between eight C5 SNPs and AMD.
- These initial associations appeared independent of known AMD risk factors like CFH Y402H and LOC387715 A69S.
- However, none of the observed associations between C5 SNPs and AMD could be consistently replicated in the independent study populations.
Conclusions:
- Despite the known role of the complement pathway and C5 protein in AMD pathology (e.g., presence in drusen), no consistent genetic associations were found between C5 SNPs and AMD across the studied populations.
- The findings do not support a significant role for the investigated C5 gene variants in the genetic susceptibility to AMD.
- Further research is needed to fully elucidate the genetic underpinnings of AMD and discuss implications for genetic screening.
Related Concept Videos
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Complement System
iPS Cell Differentiation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Alzheimer Disease ll: Pathophysiology

